The Initial Vascular Access Type Contributes to Inflammation in Incident Hemodialysis Patients

Table 3

Medications upon study entry. ASA: aspirin; ACEI/ARB: angiotensin converting enzyme inhibitor or angiotensin receptor blocker; ESA: erythropoietin stimulating agent.

	TC	AVF	AVG	𝑃 value
Statin	55%	50%	70%	ns
ASA	28%	64%	70%	0.009
Beta-blocker	70%	79%	80%	ns
Insulin	48%	43%	80%	ns
Oral hypoglycemic	35%	0	20%	0.03
Phosphate binder	33%	21%	30%	ns
Vitamin D	43%	43%	50%	ns
ACEI/ARB	28%	50%	60%	ns
ESA	38%	29%	90%	0.004